Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics

Gynecologic Oncology

Volumn 101, Issue 1, 2006, Pages 97-101

  Antila, Riitta ^a   Jalkanen, Jyrki ^a   Heikinheimo, Oskari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Diagnostics; Ovarian cancer; Serum tumor markers; Ultrasonography

Indexed keywords

APROTININ; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; ASCITES FLUID; BREAST CANCER; CANCER LOCALIZATION; CANCER PATIENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DISEASE MARKER; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CARCINOMA; OVARY METASTASIS; PARITY; PERIOPERATIVE PERIOD; PERITONEUM ADHESION; PERITONEUM CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MIDDLE AGED; OVARIAN NEOPLASMS; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 33644522401     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.046     Document Type: Article

References (15)

1. R.T. Parker, and J.L. Curie M. Coppleson J. Monaghan P. Morrow M. Tattersall Gynecologic Oncology 2nd edition 1992 Churchill Livingstone Edinburgh 987 1000
2. T. Ulbright, L. Roth, and F. Stehman Secondary ovarian neoplasia: a clinicopathologic study of 35 cases Cancer 53 1984 1164 1174
3. E. Petru, H. Pickel, M. Heydarfadai, M. Lahousen, J. Haas, and H. Schaider Nongenital cancers metastatic to the ovary Gynecol. Oncol. 44 1992 83 86
4. D. Perucchini, R. Caduff, G. Schar, D. Fink, and O.R. Kochli Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 19781990 Geburtshilfe Frauenheilkd. 56 1996 351 356
5. F. Kikkawa, K. Ino, S. Nomura, H. Ishikawa, K. Kuzuya, and O. Yamamuro Prognostic factors of secondary ovarian carcinoma Oncology 63 2002 123 129
6. R. Moore, M. Chung, G. Cornelius, W. Gajewski, and M. Steinhoff Incidence of metastasis to the ovaries from nongenital tract primary tumors Gynecol. Oncol. 93 2004 87 91
7. N.A. Janovski, and T.L. Paramanandhan Ovarian Tumors 1973 Goerge Thieme Publishers Stuttgart 130 141
8. D. Brown, K. Zou, C. Tempany, S. Silverman, B. McNeil, and A. Kurtz Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the radiology diagnostic oncology group study Radiology 219 2001 213 218
9. H.J. Choi, J.-H. Lee, S.-S. Seo, S. Lee, S.K. Kim, and J.-Y. Kim Computed tomography findings of ovarian metastases from colon cancer J. Comput. Assist. Tomogr. 29 2005 69 73
10. K. Fujiwara, Y. Ohishi, H. Koike, S. Sawada, T. Moriya, and I. Kohno Clinical implications of metastases to the ovary Gynecol. Oncol. 59 1995 124 128
11. N. Yada-Hashimoto, T. Yamamoto, S. Kamiura, H. Seino, H. Ohira, and K. Sawai Metastatic ovarian tumors: a review of 64 cases Gynecol. Oncol. 89 2003 314 317
12. L. Kowalski, A. Kanbour, F. Price, S. Fincelstein, W. Christopherson, and J. Seski A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma Cancer 79 1997 1587 1594
13. J. Bloss, M. Brady, S.Y. Liao, T. Rocereto, E. Patridge, and D. Clarke-Pearson Extraovarian peritoneal serous papillary carcinoma: a phases II trial of cisplatin and cyclophosphamide with comparison to cohort with papillary serous ovarian carcinoma-A Gynecologic Oncology Group Study Gynecol. Oncol. 89 2003 148 154
14. J. Lacey, P. Mink, J. Lubin, M. Sherman, R. Troisi, and P. Hartge Menopausal hormone replacement therapy and risk of ovarian cancer JAMA 288 2002 334 341
15. Writing group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results of the Women's Health Initiative raondomized controlled trial JAMA 288 2002 321 333